showed TGFB1 blockade‐accelerated early and late‐stage pancreatic cancer, whereas others have demonstrated tumor suppressor activity in early stages of PDAC and tumor promotion in later stages of the disease [37, 38]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.